Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-004403

Odonate Therapeutics, Inc. · ODT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael S Hearne
Officer — Chief Financial Officer
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 7:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 15, 2019A40$13.85A758D
Common StockF2holding———12,946,038IBy LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3$16.29Jan 15, 2019A40A—Jan 15, 2029Common Stock4040D

Explanation of responses